Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Del Zompo

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Cephalalgia : an International Journal of Headache|May 12, 2016
High leptin levels are associated with migraine with auraClaudia Pisanu, Martin Preisig, Enrique Castelao, et al.
Human Genomics|November 7, 2015
HDAC3 role in medication consumption in medication overuse headache patients: a pilot studyClaudia Pisanu, Stefano Caproni, Donatella Congiu, et al.
Journal of Affective Disorders|June 13, 2015
Cellular models to study bipolar disorder: A systematic reviewBiju Viswanath, Sam P Jose, Alessio Squassina, et al.
Pharmacological Research|April 27, 2013
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patientsAlessio Squassina, Marta Costa, Donatella Congiu, et al.
Journal of Molecular Neuroscience : MN|March 6, 2015
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder PatientsElena Milanesi, Adva Hadar, Elisabetta Maffioletti, et al.
Clinical Drug Investigation|August 5, 2022
Cost-Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal PerspectiveAndrea Carta, Maria Del Zompo, Anna Meloni, et al.
Psychiatric Genetics|July 20, 2021
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorderMarco Pinna, Mirko Manchia, Claudia Pisanu, et al.
Psychiatric Genetics|March 20, 2002
Manic-depressive illness: an association study with the inositol polyphosphate 1-phosphatase and serotonin transporter genesMaria Paola Piccardi, Raffaella Ardau, Caterina Chillotti, et al.
Pharmacogenomics|October 4, 2011
Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorderAlessio Squassina, Mirko Manchia, Joseph Borg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 4, 2020
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findingsAlessio Squassina, Paola Niola, Juan Pablo Lopez, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Cephalalgia : an International Journal of Headache|May 12, 2016
High leptin levels are associated with migraine with auraClaudia Pisanu, Martin Preisig, Enrique Castelao, et al.
Human Genomics|November 7, 2015
HDAC3 role in medication consumption in medication overuse headache patients: a pilot studyClaudia Pisanu, Stefano Caproni, Donatella Congiu, et al.
Journal of Affective Disorders|June 13, 2015
Cellular models to study bipolar disorder: A systematic reviewBiju Viswanath, Sam P Jose, Alessio Squassina, et al.
Pharmacological Research|April 27, 2013
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patientsAlessio Squassina, Marta Costa, Donatella Congiu, et al.
Journal of Molecular Neuroscience : MN|March 6, 2015
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder PatientsElena Milanesi, Adva Hadar, Elisabetta Maffioletti, et al.
Clinical Drug Investigation|August 5, 2022
Cost-Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal PerspectiveAndrea Carta, Maria Del Zompo, Anna Meloni, et al.
Psychiatric Genetics|July 20, 2021
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorderMarco Pinna, Mirko Manchia, Claudia Pisanu, et al.
Psychiatric Genetics|March 20, 2002
Manic-depressive illness: an association study with the inositol polyphosphate 1-phosphatase and serotonin transporter genesMaria Paola Piccardi, Raffaella Ardau, Caterina Chillotti, et al.
Pharmacogenomics|October 4, 2011
Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorderAlessio Squassina, Mirko Manchia, Joseph Borg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 4, 2020
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findingsAlessio Squassina, Paola Niola, Juan Pablo Lopez, et al.
Pageof 13